According to current guidelines, in cases where a JAK2 mutation is confirmed and arterial thrombotic events such as stroke have occurred, treatment with hydroxyurea in combination with twice-daily aspirin is recommended [17,18]. The gene discussed is JAK2; the disease is stroke disorder.